Sanj K. Patel, CHAIRMAN & CEO at Kiniksa Pharmaceuticals, Ltd. (KNSA), sold 27,730 shares at $21.31 ($591K) on 2024-03-04, disclosed to the SEC on 2024-03-06.
Scheduled sale ($591k) by CHAIRMAN & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.31 | 9,406 | $200K | 33.9% |
| 2 | $21.31 | 9,406 | $200K | 33.9% |
| 3 | $22.00 | 3,336 | $73K | 12.4% |
| 4 | $21.00 | 5,582 | $117K | 19.8% |
| Total | $21.33 avg | 27,730 | $591K | 100% |
| Filing → |
| KNSA | SELL | 2026-04-08 | $364K | — | Filing → |
| KNSA | SELL | 2025-10-22 | $20.0M | — | Filing → |
| KNSA | SELL | 2025-05-28 | $4.6M | — | Filing → |